Arkuda Therapeutics

Series-B+
Biotech & Healthcare Watertown, United States Founded 2023 11-50
Total Funding $108M
Latest Round $64M Series-B+
Last Announced Feb 10, 2022
Investors 9 Backers
Decision Makers 2 Verified

About Arkuda Therapeutics

Leveraging new insights into progranulin and lysosomal biology to discover therapies to change the trajectory of neurodegenerative disease.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Watertown, United States
Year Founded 2023
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website Not publicly listed
Domain Registered Date Feb 20, 2018

Social & Network Presence

X / Twitter Profile @ArkudaTx (240 followers) Created on May 2018
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Milestone

    Company founded

    Watertown, United States

  2. Capital Raise

    Raised $64,000,000 · Series-B+

    fundraisingfox.com

  3. Capital Raise

    Raised $44,000,000 · Series-A

  4. Milestone

    X account created (@ArkudaTx)

    240 followers

  5. Milestone

    Website domain registered

Investors & Backers

9
Atlas Venture
Cormorant Asset Management
Eli Lilly
Michael J. Fox Foundation
Mission BioCapital
Pfizer Venture Investments
Pivotal bioVenture Partners
Surveyor Capital
Tekla Capital Management

Funding History

2 Rounds
Series-B+ · Feb 10, 2022
Series-A · Nov 7, 2019
$44,000,000 Source

Founders & Leadership

2

Duane Burnett

Founder

Work email & phone locked Unlock →

Gerhard Koenig

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts